The pharmaceutical industry constantly seeks to understand the intricate processes involved in drug action and metabolism. A key aspect of this is studying drug metabolites, which are the products formed when a drug is broken down by the body. One such important molecule is 5-Methoxy-2-[((4-Methoxy-3,5-Dimethyl-1-Oxido-2-Pyridinyl)Methyl)Sulfinyl]-Benzimidazole, identified by CAS 176219-04-8. This compound is recognized as a metabolite of Omeprazole, a widely prescribed medication for conditions like acid reflux and ulcers.

Understanding the formation and behavior of metabolites like 176219-04-8 is critical for pharmaceutical research and development (R&D). It helps in assessing the overall effectiveness and safety profile of a parent drug. Researchers use this specific Omeprazole metabolite as a reference standard in analytical chemistry to identify and quantify it in biological samples. This is vital for pharmacokinetic studies, which track how a drug is absorbed, distributed, metabolized, and excreted by the body. By having access to high-quality standards, NINGBO INNO PHARMCHEM CO.,LTD. supports scientists in obtaining accurate and reliable data.

Furthermore, 5-Methoxy-2-[((4-Methoxy-3,5-Dimethyl-1-Oxido-2-Pyridinyl)Methyl)Sulfinyl]-Benzimidazole is not just a subject of study but also a valuable tool in the synthesis of new compounds. As a complex chemical intermediate, it can be utilized as a building block to create novel molecules with potentially improved therapeutic properties or different applications. This dual role – as a subject of study and a synthetic intermediate – makes it a compound of significant interest for pharmaceutical companies and research institutions.

The availability of this compound from reliable manufacturers, such as NINGBO INNO PHARMCHEM CO.,LTD., is essential for advancing pharmaceutical R&D. It allows for the continuous exploration of drug mechanisms and the development of next-generation therapeutics. The commitment to quality and purity by suppliers ensures that researchers can confidently integrate this Omeprazole metabolite into their complex research and synthesis workflows, driving innovation in the pharmaceutical sector.